Renal Cancer - Results from #7780

Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mutation in a fifteen-year-old boy with renal cell carcinoma - Abstract April 24, 2013

Camera-port site metastasis of a renal-cell carcinoma after robot-assisted partial nephrectomy - Abstract April 24, 2013

Sequential therapy with targeted agents in metastatic renal cell carcinoma: Beyond second-line and overcoming drug resistance - Abstract April 23, 2013

Cabozantinib as a novel therapy for renal cell carcinoma - Abstract April 23, 2013

Rational therapy for renal cell carcinoma based on its genetic targets - Abstract April 22, 2013

Bilateral renal masses: Pathologic concordance and impact of temporal presentation - Abstract April 22, 2013

Update on contemporary management of clinically localized renal cell carcinoma - Abstract April 22, 2013

Ileocolic intussusception from metastatic renal cell carcinoma - Abstract April 22, 2013

Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma? - Abstract April 19, 2013

Renal cell carcinoma: A 12-year retrospective study of epidemiologic, therapeutic and follow-up data - Abstract April 19, 2013

Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: Progression-free survival lasting for over 3 years, a case report and review of the literature - Abstract April 19, 2013

A prospective comparison of surgical and pathological outcomes obtained after robot-assisted or pure laparoscopic partial nephrectomy in moderate to complex renal tumours: Results from a French multicentre collaborative study - Abstract April 18, 2013

Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma - Abstract April 18, 2013

Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program - Abstract April 18, 2013

High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination - Abstract April 17, 2013

The effectiveness of interferon-alpha subtypes alternation for metastasis from renal cell carcinoma - Abstract April 17, 2013

Brain metastases from renal cell carcinoma in the era of tyrosine kinase inhibitors - Abstract April 17, 2013

Adverse event profile of new targeted agents for renal cell carcinoma - Abstract April 17, 2013

Treatment patterns: Targeted therapies indicated for first-line management of metastatic renal cell carcinoma in a real-world setting - Abstract April 17, 2013

Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy - Abstract April 17, 2013

Page 390 of 456